FDA Adverse Event Injury Summary report: N

OSSEOGUARD FLEX

MDR report key: 23794916 · Received December 12, 2025

Report

Report Number
2249852-2025-00065
Event Type
Injury
Date Received
December 12, 2025
Report Date
December 12, 2025
Manufacturer
COLLAGEN MATRIX, INC.
Product Code
NPL
PMA / PMN Number
K090216
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THIS MEDICAL DEVICE REPORT (MDR) IS BEING SUBMITTED OUTSIDE THE STANDARD 30-DAY REPORTING TIMEFRAME DUE TO CORRECTIVE ACTIONS TAKEN FOLLOWING A NONCONFORMITY IDENTIFIED DURING AN MDSAP AUDIT /INSPECTION.

Description of Event or Problem · 0

THIS ADVERSE EVENT OCCURRED OUTSIDE OF THE U.S. HOWEVER, AS THERE IS A SIMILARLY MARKETED DEVICE IN THE U.S., AN MDR IS BEING FILED. COMPLAINT RECEIVED THROUGH CLINICAL DATA COLLECTION. AN OSSEOGUARD FLEX MEMBRANE, REF NO. OGF1520, WAS UTILIZED DURING A PROCEDURE FOR FILLING OF BONE DEFECTS AFTER ROOT RESECTION, CYSTECTOMY OR REMOVAL OF RETAINED TEETH AT SITE 21/22. THE CLINICIAN REPORTED THE ADVERSE EVENT AS "LOSS OF BONE GRAFT MATERIAL". THE MEMBRANE WAS HYDRATED PRIOR TO PLACEMENT WITH STERILE SALINE. ENDOBON BONE GRAFT MATERIAL WAS ALSO USED. (NOT A COLLAGEN MATRIX, INC. PRODUCT). STABILIZED WITH SUTURES 5.0 CORALENE. PRIMARY CLOSURE WAS ACHIEVED. DENTAL IMPLANT NOT PLACED: DENTAL BRIDGE IS PREFERRED BECAUSE OF AESTHETICS AND PREDICTABILITY. NO OTHER PRODUCTS WERE USED, NO COMPLICATIONS OCCURRED DURING IMPLANTATION AND NO OTHER CONCOMITANT MEDICAL TREATMENT WAS PERFORMED. POST-OPERATIVE INSTRUCTIONS INCLUDED ANTIMICROBIAL ORAL RINSE: PERIO-AID. FOLLOW-UP VISIT WAS (B)(6) 2023 FOR THE ASSESSMENT OF BONE GRAFT OUTCOME. WOUND HEALING WAS UNEVENTFUL. NO SURGICAL/MEDICAL INTERVENTION WAS REQUIRED. PERIODONTAL DEFECT REGENERATION WAS SUCCESSFUL. NO OTHER PATIENT INFORMATION WAS MADE AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2759197 OSSEOGUARD FLEX COLLAGEN DENTAL MEMBRANE IV NPL COLLAGEN MATRIX, INC. OGF1520 BDMU22A1

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other